CorMedix Inc. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$312M
Cost of Revenue
$22M
Gross Profit
$276M
R&D
$19M
SG&A
—
D&A
$677K
Operating Income
$150M
EBITDA
$151M
Interest Expense
$3M
Interest Income
$4M
Other Income/Expense
$-1M
Pretax Income
$150M
Tax Provision
$-13M
Net Income
$163M
Gross Margin
88.5%
Operating Margin
48.2%
Net Margin
52.3%
Effective Tax Rate
-8.7%
Deferred Tax Assets
$68M
DTA Valuation Allowance
$113M
Tax Credit Carryforwards
$3M
NOL Carryforwards
$92
ETR (Continuing Operations)
-8.7%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
6.9%
ETR Foreign Differential (pp)
0.0%
Operating Lease Cost
$204K
Revenue YoY Variation
617.0%
Income YoY Variation
771.6%